Specialized Medical Company · TADAWUL:4019
Specialized Medical — Q1 2025 Earnings Presentation
6 slides from Specialized Medical's earnings presentation, Jul 23, 2025
Slide 1: Project Oxygen — Q1 2025 Update
Project Oxygen — Q1 2025 Update
Slide 2: Disclaimer
This presentation has been prepared by Specialized Medical Company (the “Company (the “Company”) for background purposes only and does not purport to be full, accurate or complete. No reliance may be placed for any purpose on the information included herein or its accuracy, fairness or completeness.
Slide 3: Inpatient and outpatient revenue growth Q1 2025 vs Q1 2024
1 2 1 Outpatien t Inpatient revenues grew by ~1% YoY, Inpatient Outpatient reflecting the Company’s successful shift toward high-performing acute specialties, which fully offset the 1.6% YoY impact of the strategic phase-out of growth ~150 LTC beds that took place towards the end of September 2024 3
Slide 4: Number of Inpatient Beds and Outpatient Clinics
Number of Inpatient Beds Number of Outpatient Clinics 20 clinics at SMC 2 became A operational as of February 2025 740 578 11 clinics at SMC 1 were B operational as of April 2025 286 266 Remaining +29 clinics (based on the +60 additional clinics to be added) are set to C come online in phased rollou
Slide 5: Inpatient and Outpatient Visits, record May
1 Number of Inpatient Visits Number of Outpatient Visits May marked a record month with visits exceeding 150k, driven by ramp-up at new SMC 2 385.1k clinics 363.2k 61.4k 57.0k 2 Performance remains on track with full-year guidance Q1 2024 A Q1 2025 A Q1 2024 A Q1 2025 A Source: Management Informatio
Slide 6: Margins and expansion-related pre-operating costs
Margin % Expansion related pre-operating fixed costs (rent, salaries for non-revenue generating doctors and nurses, 100.0 94.3 etc.) Full corporate rebranding campaign along with advisory Q1 2024 A Q1 2025 A fees incurred in relation to legal and governance protocols as the Company transitions to a
Specialized Medical Company — Q1 2025 Earnings Presentation on 6ix